Latest debt-to-equity ratio for POMDOCTOR: -1.01 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-1.01
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
POMDOCTOR (POM) currently reports a debt-to-equity ratio of -1.01. That is below the sector sector average of 0.2. Use the charts on this page to explore POMDOCTOR's debt-to-equity ratio history and peer comparisons.
POMDOCTOR's debt-to-equity ratio of -1.01 is lower than the its sector sector average of 0.2. That is roughly 601.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The debt-to-equity ratio is a valuation multiple that relates POMDOCTOR's market price to a fundamental measure such as earnings, sales, or book value. At -1.01, POM can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current debt-to-equity ratio of -1.01, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 0.2. From there, open related valuation or income-statement pages for POMDOCTOR, and consider following POM for alerts when major investors trade the stock.